Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Amber has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Baltic amber is distinguished from other fossil resins by its succinic acid content, which is where the name succinite comes from. Any claim made for amber internally traces back to succinate, a normal intermediate of the citric acid cycle. Buying isolated succinic acid delivers that compound at a known dose, which amber does not.
Amber and chamomile appear together in European folk practice around infant comfort, which is a cultural pairing rather than a pharmacological one. Chamomile has its own literature; amber taken by mouth does not. Presented as tradition, this is honest, and presented as mechanism it is not.
Succinate is handled inside the citric acid cycle, and several enzymes of that cycle and of the ATP machinery downstream require magnesium. Magnesium adequacy therefore sits underneath any pathway that succinate feeds into. This is background biochemistry and not a reason to expect an effect from amber itself.
Succinate dehydrogenase, the enzyme that oxidises succinate, is a flavoprotein carrying FAD derived from riboflavin. Riboflavin status therefore governs how succinate moves through the cycle. Again, this is the biochemistry of succinate and says nothing about whether a fossil resin delivers any.
Succinate dehydrogenase passes electrons to the quinone pool, which is complex II of the respiratory chain, so ubiquinone is the direct acceptor downstream of succinate. The two sit adjacent in the same pathway. The relationship is textbook electron transport, not evidence for amber as a supplement.
Nothing specific on file for Amber. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.4 sources behind our Amber verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 106 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Amber is, not how risky it is. A report is not proof Amber caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.